In This Section
Home>CBH Members>Member Resources>Pharmacy Education and Resources for Members

Pharmacy Education and Resources for Members

As a reminder, in accordance with state standards, CBH does not have a pharmacy benefit, and as such is not responsible for the approval or rejection of medication claims through your local pharmacy. However, to assist you in accessing medications, below we have compiled various medical- and pharmacy-related information from the insurance companies that serve Medicaid recipients in Philadelphia.

After initial outreach to the physical health insurance company, if you experience persistent difficulty accessing medications for your mental health or addiction treatment, please contact CBH.PharmacyInitiatives@phila.gov.

Please Note: Effective January 1, 2020, Pennsylvania Medicaid began operating a central Preferred Drug List/Formulary. If there are any questions about the medications not captured within the state PDL, reach out to your individual insurance company using the contact information provided below.

Naloxone Notice

Naloxone Hydrochloride (Naloxone) is a medication indicated for reversal of a drug overdose that is the result of consumption or use of one or more opioid-related drugs causing a drug overdose event (opioid-related overdose).

For more information about Naloxone, please see the Pennsylvania Department of Health  Naloxone Standing Order DOH-001-2023 (Effective 1/17/2023)

Education for Members, Caregivers, and Parents
HealthChoices Medicaid Health Plans
Community Health Choices Medicaid Health Plans

CBH Providers: Stay up to date by signing up for our News Blast